MX2023002613A - Composiciones de matriquina derivada de tejidos y metodos para su realizacion. - Google Patents
Composiciones de matriquina derivada de tejidos y metodos para su realizacion.Info
- Publication number
- MX2023002613A MX2023002613A MX2023002613A MX2023002613A MX2023002613A MX 2023002613 A MX2023002613 A MX 2023002613A MX 2023002613 A MX2023002613 A MX 2023002613A MX 2023002613 A MX2023002613 A MX 2023002613A MX 2023002613 A MX2023002613 A MX 2023002613A
- Authority
- MX
- Mexico
- Prior art keywords
- tissue
- composition
- derived
- peptides
- matrikine
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 210000001519 tissue Anatomy 0.000 abstract 3
- 230000017423 tissue regeneration Effects 0.000 abstract 2
- 208000002874 Acne Vulgaris Diseases 0.000 abstract 1
- 201000004624 Dermatitis Diseases 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 206010000496 acne Diseases 0.000 abstract 1
- 208000010668 atopic eczema Diseases 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 230000005754 cellular signaling Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 210000000981 epithelium Anatomy 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 230000030968 tissue homeostasis Effects 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Paper (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se divulga una composición para administración tópica en un epitelio. La composición comprende un matrisoma desarmado que incluye uno o más péptidos de fragmentación enzimática provenientes del tejido biológico. La composición comprende además uno o más excipientes farmacéutica o cosméticamente aceptados. El matrisoma desarmado puede ser fragmentado por degradación mediante una o mas enzimas para producir el uno o más péptidos. El uno o más péptidos pueden estar configurados para retener la capacidad de señalización celular, promoviendo de este modo uno o más de regeneración tisular, reparación tisular, y homeostasis tisular. La composición puede utilizarse para tratar un tejido tal como tejido de la piel que presenta cicatrices, acné, eczema, psoriasis, y otras condiciones de la piel.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063075638P | 2020-09-08 | 2020-09-08 | |
| PCT/US2021/049432 WO2022055974A1 (en) | 2020-09-08 | 2021-09-08 | Tissue-derived matrikine compositions and methods therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023002613A true MX2023002613A (es) | 2023-03-27 |
Family
ID=78135106
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023002613A MX2023002613A (es) | 2020-09-08 | 2021-09-08 | Composiciones de matriquina derivada de tejidos y metodos para su realizacion. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20240024431A1 (es) |
| EP (1) | EP4210675A1 (es) |
| JP (1) | JP2023547984A (es) |
| KR (1) | KR20230065274A (es) |
| CN (1) | CN116546971A (es) |
| AU (1) | AU2021340630A1 (es) |
| CA (1) | CA3191359A1 (es) |
| IL (1) | IL301123A (es) |
| MX (1) | MX2023002613A (es) |
| WO (1) | WO2022055974A1 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023215764A2 (en) * | 2022-05-03 | 2023-11-09 | The Trustees Of Columbia University In The City Of New York | Pathological remodeling of distal lung matrix in end-stage cystic fibrosis patients |
| WO2024011235A1 (en) | 2022-07-08 | 2024-01-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Methods and compositions for improving wound healing |
| CN116970071B (zh) * | 2023-09-22 | 2023-12-01 | 英特菲尔(成都)生物制品有限责任公司 | 一种具有抗衰活性的重组弹性蛋白及其制备方法与应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070020220A1 (en) | 2005-04-27 | 2007-01-25 | Procter & Gamble | Personal care compositions |
| CN105727372A (zh) * | 2016-02-25 | 2016-07-06 | 烟台隽秀生物科技有限公司 | 一种温敏性宫腔修复凝胶及其制备方法 |
-
2021
- 2021-09-08 MX MX2023002613A patent/MX2023002613A/es unknown
- 2021-09-08 AU AU2021340630A patent/AU2021340630A1/en active Pending
- 2021-09-08 EP EP21791085.0A patent/EP4210675A1/en active Pending
- 2021-09-08 JP JP2023515618A patent/JP2023547984A/ja active Pending
- 2021-09-08 IL IL301123A patent/IL301123A/en unknown
- 2021-09-08 CA CA3191359A patent/CA3191359A1/en active Pending
- 2021-09-08 KR KR1020237009538A patent/KR20230065274A/ko active Search and Examination
- 2021-09-08 US US18/021,660 patent/US20240024431A1/en active Pending
- 2021-09-08 CN CN202180072769.2A patent/CN116546971A/zh active Pending
- 2021-09-08 WO PCT/US2021/049432 patent/WO2022055974A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023547984A (ja) | 2023-11-15 |
| KR20230065274A (ko) | 2023-05-11 |
| WO2022055974A1 (en) | 2022-03-17 |
| US20240024431A1 (en) | 2024-01-25 |
| CA3191359A1 (en) | 2022-03-17 |
| EP4210675A1 (en) | 2023-07-19 |
| AU2021340630A1 (en) | 2023-03-16 |
| CN116546971A (zh) | 2023-08-04 |
| IL301123A (en) | 2023-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023002613A (es) | Composiciones de matriquina derivada de tejidos y metodos para su realizacion. | |
| RU2008108973A (ru) | Эмульсия типа масло-в-воде для топического нанесения в дерматологии | |
| WO2003096972A3 (en) | Angiogenesis and cardiac tissue engineering with peptide hydrogels and related compositions and methods of use thereof | |
| MX2023000316A (es) | Composiciones farmaceuticas y metodos para el tratamiento de la enfermedad de parkinson. | |
| MX2023012981A (es) | Compuestos para inhibir o degradar proteinas objetivo, composiciones que los comprenden, metodos para su preparacion y metodos para usarlos. | |
| MX2023007027A (es) | Derivado de cannabinoide como compuesto farmaceuticamente activo y metodo de preparacion del mismo. | |
| EA201590591A1 (ru) | Способ приготовления геля на основе полифенолов гранатовой кожуры для лечения воспалительных заболеваний в гинекологии | |
| KR102534457B1 (ko) | 방사선 피부염의 치료를 위한 국소 BRaF 억제제 조성물의 용도 | |
| MX2023011269A (es) | Inhibidores del inflamasoma nlrp3. | |
| JP2011001269A (ja) | 紫外線誘発皮膚炎又は一次刺激性皮膚炎の予防又は治療用外用剤 | |
| WO2021260667A3 (en) | Composition for hair follicle modulation, methods and uses thereof | |
| RU2012107715A (ru) | Лечение и/или предотвращение воспаления и фотоповреждения кожи и фотозащита кожи с помощью водорастворимого экстракта растения рода solanum | |
| MX2022009807A (es) | Metodos para tratar y prevenir arritmias por injerto. | |
| AU2017101409A4 (en) | Cosmetic composition | |
| WO2023164175A3 (en) | Protacs of malt1 | |
| CA2893966C (en) | Topical treatment of inflammatory skin conditions using a combination of aurin tricarboxylic, aurin quadracarboxylic and aurin hexacarboxylic acids | |
| CN114949089A (zh) | 一种除螨抑菌药品配方及其制备工艺 | |
| Shetty et al. | Biochemical analysis of granulation tissue in steroid and Centella asiatica (Linn) treated rats | |
| FR2831444A1 (fr) | Compositions cosmetiques ou dermatologiques pour le soin de la peau contenant un extrait de buddleja et un extrait d'anthyllis | |
| CA3051652C (en) | Glycopeptide derivatives for use in the treatment and/or prevention and/or attenuation of fibrosis diseases | |
| TW201940178A (zh) | 皮膚外用組成物 | |
| WO2021216450A8 (en) | Opioid antagonist formulations | |
| WO2011139246A1 (en) | Topical or injectable composition comprising humic acid salts and polyvinylpyrrolidone for the treatment of skin diseases | |
| MX2021000622A (es) | Composiciones topicas de quitosano conteniendo compuestos nanoestructurados metalicos para inhibir el crecimiento de microorganismos, desinflamar, regenerar y cicatrizar heridas cronicas. | |
| KR102092515B1 (ko) | 칼리크레인 5 프로테아제의 저해 활성을 갖는, 인돌-3-아세토니트릴-4-메톡시-2-S-β-D-글루코피라노사이드를 함유하는 아토피 피부염 개선 또는 예방용 화장료 조성물 |